Researchers discover a major driver of osteosarcoma

Three staff neurologists are expected to exit Western North Carolina’s Mission Hospital by the end of September, a report indicated. Their departure would leave just

Im­bria Phar­ma­ceu­ti­cals’ par­tial fat­ty acid ox­i­da­tion in­hibitor im­proved out­comes in Phase II non-ob­struc­tive hy­per­trophic car­diomy­opa­thy pa­tients, with the com­pa­ny not­ing that the as­set’s ef­fi­ca­cy could